TSE:HMMJ

11.11
0.09 (0.80%) 1d
0

Related posts

Aphria gives the TSX a nice buzz while U.S. banks report mixed earningsOne Year of Cannabis Investing: Happy Birthday, Mary Jane!Oil wobbles, weed sinks, the Fed cuts?
Investor Insights

This summary was created by AI, based on 1 opinions in the last 12 months.

According to the reviews from different experts, HMMJ-T, the medical marijuana company, has been experiencing a downturn for the past 5 years due to investor apathy. However, there is growing public support for legalizing marijuana in the US, where the company has exposure. The experts recommend starting with a small position due to the sector's volatility, indicating potential opportunities amidst the challenges.

Consensus
Positive
Valuation
Undervalued
TOP PICK

This asset class has been down for 5 years during a long period of investor apathy. But when an asset class has been down for longer than 3 years, you start to consider it. HMMJ has US exposure where there is growing public support for legalizing canopy. Maybe start with a small position. This is a volatile sector.

E.T.F.'s
DON'T BUY
Are you investing or gambling? Some invest in hot sectors like cannabis or blockchain without understanding them. He's never owned this, because it's gambling. He avoids the sector for the same reason.
E.T.F.'s
DON'T BUY
Wouldn't buy. Firstly on principle, as they're active managers. The ETF owns the good, the bad, and the ugly. There are a lot of garbagy business models and bottom feeders out there.
E.T.F.'s
BUY ON WEAKNESS
The yield is not a dividend. Because of M&A, there is a capital distribution every year. Long term CBDs are going to be a big part of the future. It could be an election issue in the US. These companies don't make any money so it is speculative. He likes it longer term.
E.T.F.'s
PARTIAL BUY
He started to nibble. Expect a lot of volatility. He likes it on valuation.
E.T.F.'s
PARTIAL BUY
He has said for a couple of years that he wants the industry to mature. He thinks there is some value there at this point. There are really no earnings, however. Usually when a correction hits, stocks without earnings get hit first. He has been buying below $9. Don't commit a lot of money. Just nibble.
E.T.F.'s
DON'T BUY
Not just discouraging performance, but catastrophic. None of these things are making any money. He won't be buying in this sector. He likes earnings.
E.T.F.'s
DON'T BUY
The problem he has with this is that you can't get capacity. He stays away from it.
E.T.F.'s
DON'T BUY
He's never liked marijuana stocks. The hype wasn't justified and they got way ahead of themselves. This will be regulated like alcohol which means tight returns.
E.T.F.'s
DON'T BUY
Marijuana stocks There has been a sell off because of Canntrust and no one is making money. There will be a lot of research to be done on the benefits. However, the best days to make profit here are probably behind us.
E.T.F.'s
BUY ON WEAKNESS
Anytime you are investing in an area with such massive potential growth opportunities, you will see volatility. If you buy a little and more yet in corrections, it is a way to play it. Wait for good stiff corrections.
E.T.F.'s
BUY

HMMJ vs. HMUS. A monstrous opportunity, but you're going to suffer volatility. Go slow, get in over time, and keep it to a smaller proportion of your portfolio. Market weighted. The US exposure is to companies operating legally, and there can't be any recreational use. With HMUS, you're tapping into a bigger market. For example, Charlotte's Web is planning to sell CBD infused products through Kroeger. This scale dwarfs the whole Canadian market. Valuations are high because of the growth potential. If you're a marijuana investing aficionado, you'd want to own both.

E.T.F.'s
COMMENT
Any vice will do well, and so will this. Horizon makes great ETFs. That said, ETF's aren't always the best. Instead of buying the weed basket, buy the leader--Canopy.
E.T.F.'s
DON'T BUY
Companies on this don't have any earnings. With out earnings he doesn't want it.
E.T.F.'s
COMMENT
How does this pay a yield if weed stocks don't? It does pay a dividend, perhaps from capital gains from buying and selling those weed stocks within the ETF. He doesn't think cannabis will be an exciting industry, but will wind up like the liquor business.
E.T.F.'s
Showing 1 to 15 of 57 entries

Horizon's Medical Marijuana(HMMJ-T) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Horizon's Medical Marijuana is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Horizon's Medical Marijuana(HMMJ-T) Frequently Asked Questions

What is Horizon's Medical Marijuana stock symbol?

Horizon's Medical Marijuana is a Canadian stock, trading under the symbol HMMJ-T on the Toronto Stock Exchange (HMMJ-CT). It is usually referred to as TSX:HMMJ or HMMJ-T

Is Horizon's Medical Marijuana a buy or a sell?

In the last year, there was no coverage of Horizon's Medical Marijuana published on Stockchase.

Is Horizon's Medical Marijuana a good investment or a top pick?

Horizon's Medical Marijuana was recommended as a Top Pick by on . Read the latest stock experts ratings for Horizon's Medical Marijuana.

Why is Horizon's Medical Marijuana stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Horizon's Medical Marijuana worth watching?

0 stock analysts on Stockchase covered Horizon's Medical Marijuana In the last year. It is a trending stock that is worth watching.

What is Horizon's Medical Marijuana stock price?

On 2024-03-28, Horizon's Medical Marijuana (HMMJ-T) stock closed at a price of $11.11.